Ads
related to: prostate+cancer%2C+cell
Search results
Investors Buy High Volume of BioNTech Call Options (NASDAQ:BNTX)
ETF DAILY NEWS· 5 days agoBioNTech SE (NASDAQ:BNTX – Get Free Report) was the recipient of some unusual options trading on Wednesday. Traders bought 2,346 call options on the stock. This is an increase of 59% compared ...
ValiRx (LON:VAL) Stock Price Down 10%
ETF DAILY NEWS· 6 days agoShares of ValiRx plc (LON:VAL – Get Free Report) dropped 10% on Tuesday . The company traded as low as GBX 3.55 ($0.05) and last traded at GBX 3.60 ($0.05). Approximately 9,956,905 shares changed ...
Assetmark Inc. Boosts Stock Position in BeiGene, Ltd. (NASDAQ:BGNE)
ETF DAILY NEWS· 3 days agoAssetmark Inc. boosted its holdings in shares of BeiGene, Ltd. (NASDAQ:BGNE – Free Report) by 13.4% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange ...
Alpha Tau Medical (NASDAQ:DRTS) Receives Buy Rating from HC Wainwright
ETF DAILY NEWS· 6 days agoHC Wainwright reissued their buy rating on shares of Alpha Tau Medical (NASDAQ:DRTS – Free Report) in a research report report published on Wednesday, Benzinga reports. They currently have a ...
23andMe (ME) Q4 FY24 Earnings: Revenue Beats Estimates Despite 3
Guru Focus· 5 days agoRevenue: $64 million for Q4 FY24, exceeding analyst estimates of $55.82 million and down 31% year-over-year from $92.4 million.Annual Revenue: $219.6 million f
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 5 days agoSOUTH SAN FRANCISCO, Calif., May 23, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics and biopharmaceutical company, reported its financial results for the fourth quarter and full year of fiscal year 2024 (
Alpha Tau Medical Ltd. to Post Q2 2025 Earnings of ($0.13) Per Share, HC Wainwright Forecasts...
ETF DAILY NEWS· 4 days agoAlpha Tau Medical Ltd. (NASDAQ:DRTS – Free Report) – HC Wainwright issued their Q2 2025 earnings per share estimates for shares of Alpha Tau Medical in a research report issued on Wednesday, ...
Cogent Biosciences Appoints Cole Pinnow as Chief Commercial Officer - Cogent Biosciences...
Benzinga· 5 days agoCogent Biosciences, Inc. COGT, a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced the appointment of Cole Pinnow as Chief Commercial ...